期刊文献+

HPLC法测定三氟柳的含量及有关物质 被引量:3

Determination of Content of Triflusal and Its Related Substances by HPLC
下载PDF
导出
摘要 采用HPLC法测定三氟柳的含量及有关物质。色谱柱为Kromasil C18(250mm×4.6mm,5μm),流动相为0.3%磷酸水溶液-乙腈-四氢呋喃(60∶30∶10),流速1.0mL.min-1,检测波长278nm。结果表明,三氟柳与各杂质及降解产物分离良好,在0.081~0.81mg.mL-1范围内,峰面积与浓度呈良好的线性关系(R=0.9992),平均回收率为98.25%,RSD为1.11%,最低检测限为1.62ng。该方法操作简便、灵敏、准确度高,可用于三氟柳的质量控制。 A HPLC method for determination of content of triflusal and its related substances was established.The analysis was performed on Kromasil C18 column(250 mm×4.6 mm,5 μm) with detective wavelength at 278 nm.The mobile phase consisted of a mixture of 0.3% phosphoric acid-acetonitrile-tetrahydrofuran(60∶30∶10) with the flow rate of 1.0 mL·min-1.Results showed that,triflusal was separated with the impurities and its degradation substances efficiently.The linearity of the triflusal curve was well correlated(R=0.9992) within the range of 0.081~0.81 mg·mL-1;the average recovery was 98.25% with RSD of 1.11%,The limit of detection was 1.62 ng.The method was proved to be simple,sensitive and accurate,which could be applied to quality control of triflusal.
出处 《化学与生物工程》 CAS 2011年第10期91-94,共4页 Chemistry & Bioengineering
关键词 三氟柳 测定 含量 有关物质 高效液相色谱法 triflusal determination content related substance HPLC
  • 相关文献

参考文献4

  • 1McNeely W,Goa K. Triflusal[J]. Drugs,1998,55(6) :823-833.
  • 2Murdoch D,Plosker G L. Triflusal:A review of its use in cerebral infarction and myocardial infarction,and as thromboprophylaxis in atrial fibrillation[J]. Drugs,2006,66(5) :671-692.
  • 3European Pharmacopoeia Commission Strasbourg: European Di rectorate for the Quality of Medicine Health Care EP7. 0 [S].2010:3137-3138.
  • 4国家药典委员会.中国药典(二部)[s].北京:中国医药科技出版社,2010:附录29,60.

共引文献54

同被引文献26

  • 1MCNEELY W, GOA K. Triflusal [ J ]. Drugs, 1998,55 ( 6 ) : 823 -833.
  • 2MURDOCH D, PLOSKER G. Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation [ J ]. Drugs, 2006,66 (5) :671-692.
  • 3MATIAS-GUIU J, FERRO J,ALVAREZ-SABIN J, et al. Co- mparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction:the TACIP study: a randomized, double-blind, multicenter trial [ J ]. Stroke, 2003,34(4) : 840-848.
  • 4CRUZ-FERNANDEZ J, LOPEZ-BESCOS L, GARCIA-DOR- ADO D, et al. Randomized comparative trial of triflusal and aspirin following acute myocardial infarction [ J ]. Eur HeartJ,2000,21 (6) : 457-465.
  • 5PEREZ-GOMEZ F, EDURADO A, JOSE A, et al. Compara- tive effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation:a randomized multieenter study[J]. J Am Coil Cardiol, 2004, 44 (8) : 1557-1566.
  • 6ANNINOS H, ANDRIKOPOULOS G, PASTROM ASS, et al. Triflusal: An old drug in modern antiplatelet therapy. Review of its action, use, safety and effectiveness[ J]. Hellenic J Cardiol, 2009,50(3) :199 -207.
  • 7MURDOCH D, PLOSKER GL. Triflusal: A review of its use in cerevral infarction and myocardial infarction, and as thrombopro- phylaxis in atrial fibrillation [ J ]. Drugs, 2006,66 ( 5 ) : 671 - 692.
  • 8QUETGLAS EG, CAMPANERO biA, SADABA B, et al. Bio- equivalence of two oral formulationa of triflusal capsules in health- y volunteers [ J ]. Arznelmittel-Forschung ( Drug Research ) , 2008, 58(6) :283 -287.
  • 9CHO HY, JEONG TJ, LEE YB. Simultaneous determination of triflusal and its major active metabolite, 2-hydroxy-4-trifluorom- ethyl benzoic acid, in rat and human plasma by high-performance liquid chromatography[ J ]. J Chromatogr B Analyt Technol Bi- omed Life Sci,2003, 798(2) :257 -264.
  • 10IZQUIERDO I, BORJA J, ROVIRA S, et al. Comparative bio- availability study of triflusal oral solution vs. triflusal capsules in healthy subjects. A single, randomized, two-way cross-over, open-label phase I study [ J]. Arzneimittelforschung, 2010, 60 (1) :36 -41.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部